Mirae Asset Global Etfs Holdings Ltd. Ani Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 8,135 shares of ANIP stock, worth $499,814. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,135Holding current value
$499,814% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANIP
# of Institutions
206Shares Held
15.9MCall Options Held
24KPut Options Held
7.7K-
Black Rock Inc. New York, NY2.66MShares$163 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$88.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX655KShares$40.3 Million0.01% of portfolio
-
State Street Corp Boston, MA645KShares$39.6 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY604KShares$37.1 Million1.14% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.07B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...